Analysis of complement receptor type 1 (CR1) expression on erythrocytes and of CR1 allelic markers in Caucasian and African American populations

Clinical Immunology and Immunopathology

Volumn 87, Issue 2, 1998, Pages 176-183

  Herrera, Amy H ^a   Xiang, Lianbin ^a   Martin, S Gail ^a   Lewis, Jerry ^b   Wilson, James G ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b TOUGALOO COLLEGE   (United States)

Author keywords

Cell surface molecules; Complement; Human; Molecular biology

Indexed keywords

COMPLEMENT COMPONENT C3B RECEPTOR;

ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CAUCASIAN; DNA CLEAVAGE; ERYTHROCYTE; HUMAN; HUMAN CELL; NEGRO; NORMAL HUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RACE DIFFERENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY;

EID: 0031804937     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1998.4529     Document Type: Article

References (60)

1. Fearon D. T., Ahearn J. M. Complement receptor type 1 (C3b/C4b receptor; CD35) and complement receptor type 2 (C3d/Epstein-Barr virus receptor; CD21). Curr. Top. Microbiol. Immunol. 153:1989;83-98.
2. Yoon S. H., Fearon D. T. Characterization of a soluble form of the C3b/C4b receptor (CR1) in human plasma. J. Immunol. 134:1985;3332-3338.
3. Paccaud J.-P., Carpentier J.-L., Schifferli J. A. Direct evidence for the clustered nature of complement receptors type 1 on the erythrocyte membrane. J. Immunol. 141:1988;3889-3894.
4. Chevalier J., Kazatchkine M. D. Distribution in clusters of complement receptor type one (CR1) on human erythrocytes. J. Immunol. 142:1989;2031-2036.
5. Madi N., Paccaud J.-P., Steiger G., Schifferli J. A. Immune complex binding efficiency of erythrocyte complement receptor 1 (CR1). Clin. Exp. Immunol. 84:1991;9-15.
6. Taylor R. P., Pocanic F., Reist C., Wright E. L. Complement-opsonized IgG antibody/dsDNA immune complexes bind to CR1 clusters on isolated human erythrocytes. Clin. Immunol. Immunopathol. 61:1991;143-160.
7. Fearon D. T. Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte. J. Exp. Med. 152:1980;20-30.
8. Cornacoff J. B., Hebert L. A., Smead W. L., VanAman M. E., Birmingham D. J., Waxman F. J. Primate erythrocyte immune complex clearing mechanism. J. Clin. Invest. 71:1983;236-247.
9. Lobatto S., Daha M. R., Voetman A. A., Evers-Schouten J. H., Van Es A. A., Pauwels E. K. J., Van Es L. A. Clearance of soluble aggregates of human immunoglobulin G in healthy volunteers and chimpanzees. Clin. Exp. Immunol. 68:1987;133-141.
10. Schifferli J. A., Ng Y. C., Estreicher J., Walport M. J. The clearance of tetanus toxoid/anti-tetanus toxoid immune complexes from the circulation of humans. J. Immunol. 140:1988;899-904.
11. Davies K. A., Peters A. M., Beynon H. L. C., Walport M. J. Immune complex processing in patients with systemic lupus erythematosus. J. Clin. Invest. 90:1992;2075-2083.
12. Waxman F. J., Hebert L. A., Cornacoff J. B., VanAman M. E., Smead W. L., Kvarit E. H., Birmingham D. J., Taguiam J. M. Complement depletion accelerates the clearance of immune complexes from the circulation of primates. J. Clin. Invest. 74:1984;1329-1340.
13. Waxman F. J., Hebert L. A., Cosio F. G., Smead W. L., VanAman M. E., Taguiam J. M., Birmingham D. J. Differential binding of immunoglobulin A and immunoglobulin G1 immune complexes to primate erythrocytes in vivo. Immunoglobulin A immune complexes bind less well to erythrocytes and are preferentially deposited in glomeruli. J. Clin. Invest. 77:1986;82-89.
14. Lobatto S., Daha M. R., Breedveld F. C., Pauwels E. K. J., Evers-Schouten J. H., Voetman A. A., Cats A., Van Es L. A. Abnormal clearance of soluble aggregates of human immunoglobulin G in patients with systemic lupus erythematosus. Clin. Exp. Immunol. 72:1988;55-59.
15. Schifferli J. A., Ng Y. C., Paccaud J.-P., Walport M. J. The role of hypocomplementaemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans. Clin. Exp. Immunol. 75:1989;329-335.
16. Madi N., Steiger G., Estreicher J., Schifferli J. A. Immune adherence and clearance of hepatitis B surface Ag/Ab complexes is abnormal in patients with systemic lupus erythematosus (SLE). Clin. Exp. Immunol. 85:1991;373-378.
17. Davies K. A., Erlendsson K., Beynon H. L. C., Peters A. M., Steinsson K., Valdimarsson H., Walport M. J. Splenic uptake of immune complexes in man is complement-dependent. J. Immunol. 151:1993;3866-3873.
18. Fearon D. T. Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane. Proc. Natl. Acad. Sci. USA. 76:1979;5867-5871.
19. Wilson J. G., Wong W. W., Schur P. H., Fearon D. T. Mode of inheritance of decreased C3b receptors on erythrocytes of patients with systemic lupus erythematosus. N. Engl. J. Med. 307:1982;981-986.
20. Ripoche J., Sim R. B. Loss of complement receptor type 1 (CR1) on ageing of erythrocytes. Biochem. J. 235:1986;815-821.
21. Kazatchkine M. D., Fearon D. T. Deficiencies of human C3 complement receptors type 1 (CR1, CD35) and type 2 (CR2, CD21). Immunodefic. Rev. 2:1990;17-41.
22. Walport M. J., Lachmann P. J. Erythrocyte complement receptor type 1, immune complexes, and the rheumatic diseases. Arthritis Rheum. 31:1988;153-158.
23. Barbosa J. E., Harrison R. A., Barker P. J., Lachmann P. J. An anti-peptide antibody that recognizes a neo-antigen in the CR1 stump remaining on erythrocytes after proteolysis. Clin. Exp. Immunol. 87:1992;144-149.
24. Pascual M., Danielsson C., Steiger G., Schifferli J. A. Proteolytic cleavage of CR1 on human erythrocytesin vivo. Eur. J. Immunol. 24:1994;702-708.
25. Klickstein L. B., Wong W. W., Smith J. A., Weis J. H., Wilson J. G., Fearon D. T. Human C3b/C4b receptor (CR1): demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristic of C3/C4 binding proteins. J. Exp. Med. 165:1987;1095-1112.
26. Hourcade D., Miesner D. R., Atkinson J. P., Holers V. M. Identification of an alternative polyadenylation site in the human C3b/C4b receptor (complement receptor type 1) transcriptional unit and prediction of a secreted form of complement receptor type 1. J. Exp. Med. 168:1988;1255-1270.
27. Klickstein L. B., Bartow T. J., Miletic V., Rabson L. D., Smith J. A., Fearon D. T. Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis. J. Exp. Med. 168:1988;1699-1717.
28. Dykman T. R., Cole J. L., Iida K., Atkinson J. P. Polymorphism of human erythrocyte C3b/C4b receptor. Proc. Natl. Acad. Sci. USA. 80:1983;1698-1702.
29. Wong W. W., Wilson J. G., Fearon D. T. Genetic regulation of a structural polymorphism of human C3b receptor. J. Clin. Invest. 72:1983;685-693.
30. Dykman T. R., Hatch J. A., Atkinson J. P. Polymorphism of the human C3b/C4b receptor. Identification of a third allele and analysis of receptor phenotypes in families and patients with systemic lupus erythematosus. J. Exp. Med. 159:1984;691-703.
31. Dykman T. R., Hatch J. A., Aqua M. S., Atkinson J. P. Polymorphism of the C3b/C4b receptor (CR1): characterization of a fourth allele. J. Immunol. 134:1985;1787-1789.
32. Wong W. W., Kennedy C. A., Bonaccio E. T., Wilson J. G., Klickstein L. B., Weis J. H., Fearon D. T. Analysis of multiple restriction fragment length polymorphisms of the gene for the human complement receptor type I. Duplication of genomic sequences occurs in association with a high molecular mass receptor allotype. J. Exp. Med. 164:1986;1531-1546.
33. Wong W. W., Cahill J. M., Rosen M. D., Kennedy C. A., Bonaccio E. T., Morris M. J., Wilson J. G., Klickstein L. B., Fearon D. T. Structure of the human CR1 gene. Molecular basis of the structural and quantitative polymorphisms and identification of a new CR1-like allele. J. Exp. Med. 169:1989;847-863.
34. Hourcade D., Miesner D. R., Bee C., Zeldes W., Atkinson J. P. Duplication and divergence of the amino-terminal coding region of the complement receptor 1 (CR1) gene: an example of concerted (horizontal) evolution within a gene. J. Biol. Chem. 265:1990;974-980.
35. Wong W. W., Farrell S. A. Proposed structure of the F′ allotype of human CR1. Loss of a C3b binding site may be associated with altered function. J. Immunol. 146:1991;656-662.
36. Vik D. P., Wong W. W. Structure of the gene for the F allele of complement receptor type 1 and sequence of the coding region unique to the S allele. J. Immunol. 151:1993;6214-6224.
37. Wilson J. G., Murphy E. E., Wong W. W., Klickstein L. B., Weis J. H., Fearon D. T. Identification of a restriction fragment length polymorphism by a CR1 cDNA that correlates with the number of CR1 on erythrocytes. J. Exp. Med. 164:1986;50-59.
38. Moldenhauer F., Botto M., Walport M. J. The rate of loss of CR1 from ageing erythrocytesin vivo. Clin. Exp. Immunol. 72:1988;74-78.
39. Changelian P. S., Jack R. M., Collins L. A., Fearon D. T. PMA induces the ligand-independent internalization of CR1 on human neutrophils. J. Immunol. 134:1985;1851-1858.
40. Fraker P. J., Speck J. C. Jr. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril. Biochem. Biophys. Res. Commun. 80:1978;849-857.
41. Vettore L., DeMatters M. C., Zampini P. A new density gradient system for the separation of human red blood cells. Am. J. Hematol. 8:1980;291-297.
42. Moldenhauer J. D., Fielder A. H. L., Lachman P. J., Walport M. J. Inherited deficiency of erythrocyte complement receptor type 1 does not cause susceptibility to systemic lupus erythematosus. Arthritis Rheum. 30:1987;961-966.
43. Cohen J. H. M., Caudwell V., Levi-Strauss M., Bourgeois P., Kazatchkine M. D. Genetic analysis of CR1 expression on erythrocytes of patients with systemic lupus erythematosus. Arthritis Rheum. 32:1989;393-397.
44. Kumar A., Sinha S., Khandekar P. S., Banerjee K., Srivastava L. M. Hind. Immunol. Cell Biol. 73:1995;457-462.
45. Chakraborty R., Kamboh M. I., Nwankwo M., Ferrell R. E. Caucasian genes in American blacks: new data. Am. J. Hum. Genet. 50:1992;145-155.
46. Cohen J. H. M., Lutz H. U., Pennaforte J. L., Bouchard A., Kazatchkine M. D. Peripheral catabolism of CR1 (the C3b receptor, CD35) on erythrocytes from healthy individuals and patients with systemic lupus erythematosus (SLE). Clin. Exp. Immunol. 87:1992;422-428.
47. Jurcic J. G., Caron P. C., Scheinberg D. A. Monoclonal antibody therapy of leukemia and lymphoma. Adv. Pharmacol. 33:1995;287-314.
48. Weiss L. The structure of bone marrow. Functional interrelationships of vascular and hematopoietic compartments in experimental hemolytic anemia: an electron microscopic study. J. Morph. 117:1965;467-538.
49. Ng Y. C., Schifferli J. A., Walport M. J. Immune complexes and erythrocyte CR1 (complement receptor type 1): effect of CR1 numbers on binding and release reactions. Clin. Exp. Immunol. 71:1988;481-485.
50. Beynon H. L. C., Davies K. A., Haskard D. O., Walport M. J. Erythrocyte complement receptor type 1 and interactions between immune complexes, neutrophils, and endothelium. J. Immunol. 153:1994;3160-3167.
51. Miyakawa Y., Yamada A., Kosaka K., Tsuda F., Kosugi E., Mayumi M. Defective immune adherence (C3b) receptor on erythrocytes of patients with systemic lupus erythematosus. Lancet. 2:1981;493-497.
52. Wilson J. G., Wong W. W., Murphy E. E. III, Schur P. H., Fearon D. T. Deficiency of the C3b/C4b receptor (CR1) of erythrocytes in systemic lupus erythematosus: analysis of the stability of the defect and of a restriction fragment length polymorphism of the CR1 gene. J. Immunol. 138:1987;2706-2710.
53. Walport M. J., Ross G. D., Mackworth-Young C., Watson J. V., Hogg N., Lachmann P. J. Family studies of erythrocyte complement receptor type 1 levels: reduced levels in patients with SLE are acquired, not inherited. Clin. Exp. Immunol. 59:1985;547-554.
54. Wilson J. G., Andriopoulos N. A., Fearon D. T. CR1 and the cell membrane proteins that bind C3 and C4. Immunol. Res. 6:1987;192-209.
55. Satoh H., Yokota E., Tokiyama K., Kawaguchi T., Niho Y. Distribution of theHin. Ann. Rheum. Dis. 50:1991;765-768.
56. Iida K., Mornaghi R., Nussenzweig V. Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus. J. Exp. Med. 155:1982;1427-1438.
57. Ross G. D., Yount W. J., Walport M. J., Winfield J. B., Parker C. J., Fuller C. R., Taylor R. P., Myones B. L., Lachmann P. J. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation. J. Immunol. 135:1984;2005-2014.
58. Walport M., Ng Y. C., Lachmann P. J. Erythrocytes transfused into patients with SLE and haemolytic anaemia lose complement receptor type 1 from their cell surface. Clin. Exp. Immunol. 69:1987;501-507.
59. Davies K. A., Hird V., Stewart S., Sivolapenko G. B., Jose P., Epenetos A. A., Walport M. J. A study of in vivo immune complex formation and clearance in man. J. Immunol. 144:1990;4613-4620.
60. Cosio F. G., Xiao-Ping S., Birmingham D. J., Van Aman M., Hebert L. A. Evaluation of the mechanisms responsible for the reduction in erythrocyte complement receptors when immune complexes form in vivo in primates. J. Immunol. 145:1990;4198-4206.